Overview
Arun Singavi is a Hematologist and an Oncologist in Peoria, Arizona. Dr. Singavi is rated as an Experienced provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Shwartzman Phenomenon, Venous Thromboembolism (VTE), Angiosarcoma, and Breast Cancer.
His clinical research consists of co-authoring 22 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
Accepted plan types not found. Please verify directly with the provider.
- EPO
- HMO
- PPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
13260 N. 94th Dr #203, Peoria, AZ 85381
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Banner MD Anderson Cancer Center At Banner Gateway Medical Center
I enjoy hiking, desert gardening, travel, classical music and collecting European train models. Dr. Klueppelberg is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Marginal Zone Lymphoma (MZL), Chronic Lymphocytic Leukemia (CLL), Richter Syndrome, and Chronic B-Cell Leukemia (CBCL).
Ironwood Physicians, PC
Dr. Kalmadi joined Ironwood Cancer and Research Centers in 2008 and serves as Chief Medical Officer. After finishing his medical schooling in India, Dr. Sujith Kalmadi completed his residency training and fellowship at the Cleveland Clinic in Cleveland, Ohio. He then served as academic clinical faculty at the Cleveland Clinic School of Medicine (Lerner School) in Cleveland, Ohio and subsequently at Baylor College of Medicine in Houston, Texas. During his tenure at these prestigious institutions, he pioneered several novel clinical research trials which have been lauded at national scientific meetings and published in peer reviewed journals. His areas of clinical and research interests include several solid tumors and hematological disorders. He currently resides in Chandler with his wife and three children, and enjoys tennis, chess and racquetball during his spare time. He is board certified in Internal Medicine, Hematology and Medical Oncology. Dr. Kalmadi is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Lung Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Severe Congenital Neutropenia.
Banner MD Anderson Cancer Center At Banner Gateway Medical Center
I enjoy reading, visiting with my grandkids, fishing, watching sports, and paying attention to my loving wife. Dr. Stanek is rated as a Distinguished provider by MediFind in the treatment of Marginal Zone Lymphoma (MZL). His top areas of expertise are Myelodysplastic Syndrome (MDS), Gastric Lymphoma, Non-Hodgkin Lymphoma, Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Shwartzman PhenomenonDr. Singavi isDistinguished. Learn about Shwartzman Phenomenon.
- Venous Thromboembolism (VTE)Dr. Singavi isDistinguished. Learn about Venous Thromboembolism (VTE).
- Advanced
- AnemiaDr. Singavi isAdvanced. Learn about Anemia.
- AngiosarcomaDr. Singavi isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Singavi isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Singavi isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Febrile NeutropeniaDr. Singavi isAdvanced. Learn about Febrile Neutropenia.
- Inflammatory Breast CancerDr. Singavi isAdvanced. Learn about Inflammatory Breast Cancer.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Singavi isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Mountain SicknessDr. Singavi isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Singavi isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Singavi isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Singavi isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Singavi isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.


